Oramed Pharmaceuticals (ORMP) Current Deferred Revenue (2015 - 2026)
Oramed Pharmaceuticals' (ORMP) quarterly Current Deferred Revenue came in at $1.5 million in Q1 2026, up 15.92% on a QoQ basis from $1.3 million in Q4 2025.
Oramed Pharmaceuticals (ORMP) Current Deferred Revenue (2015 - 2026) Analysis & Trends
Oramed Pharmaceuticals (ORMP) has 11 years of Current Deferred Revenue data on file, last reported at $1.5 million in Q1 2026.
- Quarterly Current Deferred Revenue changed N/A year-over-year to $1.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 million (changed N/A YoY) and the FY2025 annual result came in at $1.3 million, changed N/A from the prior year.
- Current Deferred Revenue rose to $1.5 million in Q1 2026, from $1.3 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $2.7 million in Q1 2022 to a low of $674000.0 in Q1 2023.
- A 4-year average of $1.5 million and a median of $1.3 million in 2022 frame the typical range for Current Deferred Revenue.
- The widest YoY moves for Current Deferred Revenue: up 75.06% in 2023, down 75.06% in 2023.
- Tracing ORMP's Current Deferred Revenue over 4 years: stood at $1.3 million in 2022, then sank by 49.7% to $674000.0 in 2023, then surged by 88.28% to $1.3 million in 2025, then rose by 15.92% to $1.5 million in 2026.
- The last three Current Deferred Revenue figures came in at $1.5 million (Q1 2026), $1.3 million (Q4 2025), and $986000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Oramed Pharmaceuticals | 197.61 Mn | 197.61 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 Mn |
| Mar 31, 2026 | 1.47 Mn |
| Dec 31, 2025 | 1.27 Mn |
| Sep 30, 2025 | 986,000.00 |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2023 | 674,000.00 |
| Dec 31, 2022 | 1.34 Mn |
| Sep 30, 2022 | 2.02 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2022 | 2.70 Mn |
| Nov 30, 2021 | 2.70 Mn |
| Aug 31, 2021 | 2.70 Mn |
| May 31, 2021 | 2.70 Mn |
| Feb 28, 2021 | 2.70 Mn |
| Nov 30, 2020 | 2.70 Mn |
| Aug 31, 2020 | 2.70 Mn |
| May 31, 2020 | 2.70 Mn |
| Feb 29, 2020 | 2.70 Mn |
| Nov 30, 2019 | 2.70 Mn |
| Aug 31, 2019 | 2.70 Mn |